📰 Cell Press News
Page 12 - Cell Press News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Press. Real-time updates on events, politics, business and more.
June 28, 2023
In a significant development in the fight against fatal cancers, University of Otago researchers have pinpointed a key feature that leads to the aggressive spread of colon cancer.
June 27, 2023
In a significant development in the fight against fatal cancers, University of Otago researchers have pinpointed a key feature that leads to the aggressive spread of colon cancer.
June 27, 2023
/PRNewswire/ -- Magdalena Zernicka-Goetz, PhD, was announced today as the recipient of the 2023 Ogawa-Yamanaka Stem Cell Prize by Gladstone Institutes....
June 26, 2023
In a significant development in the fight against fatal cancers, University of Otago researchers have pinpointed a key feature that leads to the aggressive spread of colon cancer
June 26, 2023
Cell, a life sciences journal, features 52 Black scientists grappling with racism in science, and providing solutions focused on equity.
June 26, 2023
In a significant development in the fight against fatal cancers, University of Otago researchers have pinpointed a key feature that leads to the aggressive spread of colon cancer. Led by Associate Professor Aniruddha Chatterjee and Drs Euan Rodger and Rachel Purcell, researchers discovered abnormalities in the DNA instruction code that lead to the aggressive spread of colorectal (bowel) cancer – Aotearoa’s second highest cause of cancer death.
June 15, 2023
Public Release: 15-Mar-2018 Cell Press IMAGE: This graphical abstract shows two waves of Denisovan ancestry have shaped present-day humans. Credit: Browning et al./Cell Modern humans co-existed and interbred not only with Neanderthals, but also with another species of archaic humans, the mysterious Denisovans. While developing a new genome-analysis method for comparing whole genomes between modern…
June 6, 2023
A group of fungi store more than 13 million tons of carbon dioxide annually.
June 5, 2023
A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.
June 5, 2023
Researchers at Sanford Burnham Prebys, collaborating with scientists from Eli Lilly and Company, have revealed the structure and function of a drug called LY3361237, which can reduce the harmful activity of the immune system to help treat autoimmune diseases.